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Abstract
Viral infections are frequently cited as a major environmental factor involved in subacute thyroiditis
and autoimmune thyroid diseases This review examines the data related to the role of viruses in
the development of thyroiditis.
Our research has been focused on human data. We have reviewed virological data for each type
of thyroiditis at different levels of evidence; epidemiological data, serological data or research on
circulating viruses, direct evidence of thyroid tissue infection. Interpretation of epidemiological and
serological data must be cautious as they don't prove that this pathogen is responsible for the
disease. However, direct evidence of the presence of viruses or their components in the organ are
available for retroviruses (HFV) and mumps in subacute thyroiditis, for retroviruses (HTLV-1, HFV,
HIV and SV40) in Graves's disease and for HTLV-1, enterovirus, rubella, mumps virus, HSV, EBV
and parvovirus in Hashimoto's thyroiditis. However, it remains to determine whether they are
responsible for thyroid diseases or whether they are just innocent bystanders. Further studies are
needed to clarify the relationship between viruses and thyroid diseases, in order to develop new
strategies for prevention and/or treatment.
Background
Viral infections are frequently cited as a major environ-
mental factor implicated in subacute thyroiditis and
autoimmune thyroid diseases [1]. The term thyroiditis
encompasses a heterogeneous group of disorders charac-
terized by some form of thyroid inflammation. To catego-
rize the different forms of thyroiditis, most
thyroidologists use the following terms: i/Infectious thy-
roiditis (which includes all forms of infection, other than
viral); ii/Subacute thyroiditis (also called subacute granu-
lomatous thyroiditis and which causes acute illness with
severe thyroid pain); iii/Autoimmune thyroid disease
which includes Hashimoto's thyroiditis (and painless thy-
roiditis also known as silent thyroiditis or subacute lym-
phocytic thyroiditis which is considered as a variant form
of chronic Hashimoto's thyroiditis) and Grave's disease;
iiii/Riedel's thyroiditis which is a very rare disease charac-
terized by extensive fibrosis and mononuclear infiltration.
This review examines the data related to the possible role
of viruses in the development of thyroiditis. We have
added thyroid lymphoma to the section on Riedel's thy-
roiditis as both diseases are known complications of
autoimmune thyroiditis. Our research has been focused
on human data but we used some animal data in order to
emphasize some mechanisms and to support such a pos-
sibility in humans. We have reviewed virological data at
different levels of evidence; epidemiological data, serolog-
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ical data which have been associated with research into
circulating viruses and direct evidence of thyroid tissue
infection.
I/Subacute and autoimmune thyroiditis: a viral infection of 
the thyroid gland?
First defined by De Quervain, subacute thyroiditis is a self-
limited inflammatory disorder of the thyroid gland. The
disease is most prevalent in females, usually characterized
by a sudden onset of neck pain and thyrotoxicosis. Clini-
cally the disease has several characteristics typical of viral
infections including a typical viral prodrome with myal-
gias, malaise and fatigue. Recurrent subacute thyroiditis
has been reported [2]. The follicles are often infiltrated,
resulting in disrupted basement membrane and rupture of
the follicles. The thyroid injury in subacute thyroiditis is
thought to be the result of cytolytic T-cell recognition of
viral and cell antigens present in an appropriate complex
[3].
I-A/Epidemiological evidence
The first descriptions showed a tendency for the disease to
follow upper respiratory tract infections or sore throats,
which explained why a viral infection has most often been
implicated as the cause. Clusters of the disease have been
reported during outbreaks of viral infection [4]. Onset of
the disease are observed between June and September and
this seasonal distribution is almost identical to that of
established infections due to some enteroviruses (Echovi-
rus, Coxsackievirus A and B), suggesting that enterovirus
infections might be responsible for a large proportion of
cases [5,6].
An association between subacute thyroiditis and HLA B35
is noted in all ethnic groups tested [7] and two-thirds of
patients manifest HLA-B35. Familial occurrence of suba-
cute thyroiditis [8] and recurrence during the course of
time [9] are associated with HLA B35. Thus, the onset of
subacute thyroiditis is genetically influenced and it
appears that subacute thyroiditis might occur through a
susceptibility to viral infection in genetically predisposed
individuals. HLA-B35 has been reported to be correlated
with chronic active hepatitis, with hepatitis B [10], with
rapid progression of AIDS [11] and with the T lymphocyte
responses against human parvovirus B19 [12]. Recently,
the medical records of 852 patients with subacute thy-
roiditis have been studied. The significant seasonal clus-
ters of subacute thyroiditis during summer to early
autumn was confirmed. According to the authors, "the
history of patients showed no obvious association with
virus infection". Unfortunately, no data on infections are
available in the paper [2].
I-B/Virological data
Virus-like particles were first demonstrated in the follicu-
lar epithelium of a patient suffering from subacute thy-
roiditis. Judging from the size, it was thought to be
influenza or mumps virus [13], which was concordant
with an increased frequency of antibodies to the influenza
B virus in patients with thyrotoxicosis [14]. The same year,
in five out of 28 patients with subacute thyroiditis, a cyto-
pathic virus was isolated by coculturing patient samples
with susceptible cell lines[15]. The agent was later studied
by electron microscopy and classified as a paramyxovirus
[16]. Subsequently, the agent was reanalyzed by immun-
ofluorescence and electron microscopy and was reclassi-
fied as a foamy virus [17]. However, the implication of
foamy virus has not been confirmed: a more comprehen-
sive study using different techniques demonstrated no
association between foamy-virus infection and thyroiditis
in 19 patients [18]. Moreover the expression of HFV gag
proteins had not been found by indirect immunofluores-
cence [19]. As part of a larger study investigating the prev-
alence of foamy-virus infection in humans, 59 patients
with thyroid disorders, including 28 with Quervain's thy-
roiditis, were analyzed by different techniques including
PCR. Again, there was no prevalence of foamy virus infec-
tion [20]. The origin of the foamy-virus-like agent in the
original publications remains unclear, but because the
more comprehensive study was unable to detect foamy-
virus infection in de Quervain patients, it is highly
unlikely that it is a causative agent of this condition [21].
Some cases could be due to the mumps virus. Subacute
thyroiditis has occurred in epidemic form: patients with
subacute thyroiditis diagnosed during a mumps epidemic
were found to have circulating anti-mumps antibodies
even without clinical evidence of mumps [22]. High titers
of mumps antibodies have been found in some patients
with subacute thyroiditis, and occasionally parotitis or
orchitis, usual in mumps, were associated with thyroiditis
[23]. In favor of thyroid infection is the fact that in two
patients out of 11 with subacute thyroiditis diagnosed
during a mumps epidemic, the mumps virus was cultured
from thyroid tissue obtained at biopsy [22].
Enteroviruses have been suspected. Patients with subacute
thyroiditis, who had no clinical evidence of viral disease,
demonstrated increases by at least four times in viral anti-
bodies. These viral antibodies included antibodies to
mumps virus, but also coxsackie, adenovirus and influen-
zae. Coxsackie viral antibodies were the most commonly
found, and the changes in their titers most closely approx-
imated the course of the disease [24]. In a case report, thy-
roiditis was attributed to enterovirus: IgM and IgG were
found at a quadruple titer against coxsackievirus B4
whereas no other antibodies were found against other
coxsackies, echoviruses or mumps [25]. In 27 consecutive
patients with subacute thyroiditis, antibody tests, virus
isolation and antigen detection were negative. Enterovirus
RNA was not detected by RT-PCR neither in blood sam-
ples nor in the thyroid tissue in the fine-needle aspirationVirology Journal 2009, 6:5 http://www.virologyj.com/content/6/1/5
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samples. Common respiratory viruses were also screened.
There was no evidence of viral infections, except one
patient who had acute CMV infection[26].
Case reports have implicated – CMV in an infant with
acute infection and – EBV in an adult female because of
positivity for Epstein-Barr virus-specific antibodies and in
a 3-year-old girl suffering from infectious mononucleosis
because of the presence of EBV DNA both in plasma and
leukocytes [27-29]. However, when thyroid specimens of
nine patients obtained by fine-needle aspiration biopsy
were examined, no EBV or CMV DNA was detected [30].
Serum virus-specific antibodies to measles, rubella,
mumps, type I herpes, chicken pox, human parvovirus
B19 and CMV were found in 10 patients during the course
of illness. In spite of the presence of IgG to each virus in
more than 70% of patients, changes in the IgG titers were
observed for those to measles, rubella, chicken pox or
CMV in 4 patients [30]. In an adult female, subacute thy-
roiditis was diagnosed one month after acute infection
suggesting that rubella virus could also be implicated
[31].
Viral antibody titers to common respiratory tract viruses
are often elevated. Since the titers fall promptly and are
not increased during recurrence [9] and since multiple
viral antibodies may appear in the same patient, the eleva-
tion could be an anamnestic response due to the inflam-
matory condition [32].
Although the search for a viral cause is usually unreward-
ing, it appears that the thyroid could respond with thy-
roiditis after invasion by a variety of different viruses and
that no single agent is likely to be causative in the syn-
drome of subacute thyroiditis.
II/Involment of viral infection in autoimmune thyroid 
diseases (AITD)
The autoimmune thyroid diseases (AITD) are frequent
[33,34]. and include Hashimoto's thyroiditis and Graves'
disease. Both disease are characterized by lymphocytic
infiltration and the presence of serum anti-thyroperoxy-
dase antibody (TPOAb) and/or anti-thyroglobulin anti-
body (TgAb) for Hashimoto's thyroiditis and TSH
receptor autoantibodies (TSHR-Ab) for Graves' disease.
The mechanisms by which infection may induce an
autoimmune response are many, and this makes infec-
tions an attractive hypothesis for disease initiation
[35,36]. Paradoxically, infections may enhance AITD but
may also be protective. Indeed, the hygiene hypothesis
implies that the immune system is educated by multiple
exposures to different infections allowing it to control
autoimmune responses better. Thus, improved living
standards associated with decreased exposure to infec-
tions are associated with an increased risk of autoimmune
disease and the lower socio-economic groups have a
reduced prevalence of thyroid autoantibodies [37,38].
However, specific infections could be a triggering factor to
disease initiation by liberating antigens (via cell destruc-
tion or apoptosis), by forming altered antigens or causing
molecular mimicry, by cytokine and chemokine secretion,
by inducing aberrant HLA-DR expression and Toll-Like
Receptor (TLR) activation. TLRs are a family of cell surface
receptors which protect mammals from pathogenic
organisms, such as viruses, and are present on non-
immune cells including thyrocytes [39]. Moreover, TLR3
recognizes double-stranded (ds) RNA, assumed to be
released by viral killing of cells. The dsRNA binding to
TLR3, mimicked in vitro by incubation with polyinosine-
polycytidylic acid [Poly (I:C)], leads not only to the induc-
tion of inflammatory responses but also to the develop-
ment of antigen-specific adaptive immunity [40]. Then,
Hashimoto's thyroiditis has been grouped with insulitis
and type-1 diabetes, colitis, and atherosclerosis as an
autoimmune and inflammatory disease associated with
TLR3/4 overexpression, which is in favor of environmen-
tal pathogens [39].
In order to give a comprehensive review, virological data
on Hashimoto's thyroiditis and Graves' disease are
exposed together in the text but are summarized in inde-
pendent tables (see tables 1, 2, 3) for each disease and
classified in terms of their levels of evidence of infection
of the thyroid tissue: epidemiological, serological (or cir-
culating viral genome) and molecular.
II-A/Epidemiological data
II-A-1/Temporal and geographical considerations
Seasonal trends, possibly related to epidemic infections,
have been described in the diagnosis or relapse of Graves'
disease with higher rates in spring and summer [41,42].
Geographical differences have also been described in Eng-
land in the incidence of Grave's disease which could be an
indirect sign of environmental factors [43].
More surprinsigly, month of birth was studied in 664
patients with Hashimoto's hypothyroidism and in 359
patients with Graves' hyperthyroidism. Patients had a dis-
tinct pattern of distribution for month of birth compared
with the general population. These differences point
towards a a seasonal viral infection as the initial trigger in
the perinatal period, the clinical disease resulting from
further specific damage over time [44].
II-A-2/Subacute thyroiditis: a trigger of thyroid autoimmunity?
Damage to the thyroid in subacute thyroiditis, which is
thought to be a virus-associated syndrome, might release
normally sequestered antigens, inducing an immuneVirology Journal 2009, 6:5 http://www.virologyj.com/content/6/1/5
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response. Unknown autoantibodies are found in patients
with subacute thyroiditis, and a higher prevalence of thy-
roid autoantibodies after a mean follow-up interval of 4
years but at low titers has been observed [45,46]. How-
ever, thyroid autoantibodies appear at low titer only,
often transiently and characterized autoimmune patholo-
gies of the thyroid do not usually occur [32]. These
autoimmune phenomena could represent a nonspecific
response to the inflammatory release of thyroid antigens
rather than a specific autoimmune disease. Rare cases of
Hashimoto's thyroiditis have been reported but several
cases of the occurrence of Graves' disease after subacute
thyroiditis have been published [47-49]. To examine
whether subacute thyroiditis triggers TSH receptor anti-
body, 1697 patients with subacute thyroiditis were tested.
Antibodies were found positive in 2% of patients but
hyperthyroidism was not always present and some of the
patients recovered from thyroid dysfunction without
treatment. Therefore, subacute thyroiditis could trigger
autoreactive B cells to produce TSH receptor antibodies
[50].
II-A-3/What about vaccination?
Previous natural infection or vaccination against measles
and/or mumps seemed to have an inhibitory effect on the
development of thyroid autoantibodies. No evidence was
Table 1: Evidence for infection in subacute thyroiditis.
in favour of infection references not in favour of infection references
Levels of data: Epidemiological
distribution of disease during outbreaks of viral infection [4,22] no obvious association with virus infection [2,9,32]
seasonal distribution from June to September [2,5,6]
Serological and/or circulating viral genome
mumps virus [22-24] mumps virus [30]
coxsackievirus [24,25,134] enterovirus [26]
adenovirus [24] HSV-1, [30]
EBV [27,28] parvovirus B19 [30]




Direct evidence of infection
human foamy virus [17] human foamy birus [18-20]
mumps [22] enterovirus [26]
CMV and EBV [30]
Table 2: Evidence for infection in Hashimoto's autoimmune thyroiditis
in favour of infection references not in favour of infection references
Levels of data: Epidemiological
antithyroid antibodies following subacute thyroiditis [32,46] euthyroidism: nonspecific autoimmune response ? [32,46]
unknown antithyroid antibodies following subacute 
thyroiditis
[45]
seasonality of month of birth [44]
HTLV-1 [52,53] SARS: central hypothyroidism [115]
HIV [65] HIV [67,68]
non-HIV retrovirus [69]
congenital rubella [88,89,91] congenital rubella [90]
HCV, HBV [107,108,110] HCV [111,112]
enterovirus infection during pregnancy [120] measles-mumps-rubella vaccination [51]
Serological and/or circulating viral genome
HTLV-1 [54-58,60,137] HIAP-1 [78]
congenital and acquired rubella [88-90,92-94]
EBV [99,100]
Parvovirus [104]
Direct evidence of infection
HTLV-1 [59] HFV [19]
rubella [87] CMV [97]
HSV [97] Enterovirus: RNA detected in various thyroid disease [119]
Parvoviru [103]
EBV [132]Virology Journal 2009, 6:5 http://www.virologyj.com/content/6/1/5
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found, that measles-mumps-rubella vaccination may trig-
ger autoimmunity: neither the prevalence nor the levels of
antibodies changed 3 months after vaccination [51].
II-B/Specific virus data
II-B-1/Retrovirus
II-B-1-a/Human T lymphotrophic virus-1 (HTLV-1)
HTLV-1 is a human retrovirus highly endemic in the Car-
ibbean islands, Central Africa and south-west Japan.
II-B-1-a1/Hashimoto's thyroiditis
Human T lymphotrophic virus-1 has been associated with
various autoimmune disorders, including Hashimoto's
thyroiditis in patients with HTLV1-associated myelopa-
thy/tropical spastic paraparesis [52,53]. Two patients who
developed Hashimoto's thyroiditis, proven with biopsy,
were HTLV-I carriers but had no myelopathy/tropical
spastic paraparesis [54]. A case-control study was then
conducted to determine the frequency of HTLV-I seropos-
itivity among patients with Hashimoto's thyroiditis and
the frequency of Hashimoto's thyroiditis in patients with
HTLV-I-associated myelopathy/tropical spastic parapare-
sis. The frequency is significantly higher in the two groups
than in the general population [55]. A high prevalence of
positivity for thyroid autoantibodies (TPOAb and/or
TgAb) and hypothyroidism have also been described in
the adult T-cell leukaemia patients and the HTLV-I carriers
[56]. In prospective studies in blood donors, the fre-
quency of anti-thyroid antibodies tended to be higher in
donors with anti-HTLV-I antibody. HTLV-I and HTLV-II
proviral load are significantly higher in the peripheral
blood of patients with Hashimoto's thyroiditis than in
asymptomatic HTLV carriers [57,58]. Thyroid tissues from
two patients with Hashimoto's thyroiditis were examined
for the presence of HTLV-I. The virus envelope protein and
signals for the mRNA were detected in many of the thyro-
cytes from one of the patients, by immunohistochemistry
and in-situ hybridization respectively. PCR-Southern
blotting revealed the presence of HTLV-I DNA although
no virus particles were found by electron microscopy. The
present findings suggest that infection of thyroid tissue
with HTLV-I is possible [59]. An association between
HTLV-I infection and autoimmune thyroiditis may be
then strongly suspected.
II-B-1-a2/Graves' disease (GD)
Serum HTLV-I antibody is found in 6% of patients with
GD, 7% of patients with chronic thyroiditis, and 2% of
patients with nodular goiter[60]. Beside the fact that anti-
HLTV-I antibody and proviral DNA is detected in periph-
eral lymphocytes of patients with GD [60,61], proviral
load in HTLV-I-infected patients with GD, as observed in
Hashimoto's thyroiditis, is significantly higher than in
asymptomatic HTLV-I carriers [57]. GD and HTLV-I infec-
tion seem to be interacting and resulting in onset of uvei-
tis [61,62]. Indeed, 5% of HTLV-I-positive patients with
GD developed uveitis, whereas none of the HTLV-I nega-
tive patients with GD nor HTLV-I-positive patients with
chronic thyroiditis or nodular goiter developed uveitis
[60]. The provirus load was significantly higher in the
uveitis patients with GD than in those without GD [63].
As in Hashimoto's thyroididtis, HTLV-I infectivity in thy-
roid was proven: HTLV-I DNA was detected by polymer-
ase chain reaction in the thyroid tissue of an HTLV-I-
infected male who was successively afflicted with GD fol-
lowed by uveitis. HTLV-I was isolated from thyroid tissue
by coculture with peripheral blood lymphocytes [64].
Table 3: Evidence for infection in Grave's disease
in favour of infection references not in favour of infection references
Levels of data: Epidemiological
seasonality of month of birth [44]
higher diagnosis and relapse rate in spring and summer [41,42]
geographical distribution [43]
antibodies or disease onset following subacute thyroiditis [47-50] nonspecific response to the inflammatory rection ? [32]
HTLV1 [62]
HIV [65] lack of anti-thyroid antibodies before the beginning of 
HAART
[75]
Serological and/or circulating viral genome
HTLV1 [57,60-62]
HIAP-1 [78]
HFV [81,84] HFV [20,82,83]
parvovirus [106] Enterovirus [121]
HHV6, HHV7 [101]
Direct evidence of infection
HTLV-1 [64]
HIV-1 [70] SV40 [72,73]
HIAP-1 [79]
HFV [19,80] HFV [83]
SV40 [85] HSV, CMV [97]Virology Journal 2009, 6:5 http://www.virologyj.com/content/6/1/5
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II-B-1-b/Human Immunodeficiency Virus (HIV)
II-B-1-b1/Hashimoto's thyroiditis
Autoimmune diseases in HIV/AIDS have been reported
with an array of autoantibodies including anti-thyroglob-
ulin and anti-thyroid peroxidase [65].
A high prevalence of subclinical hypothyroidism with
3.5% to 12.2% has been described in patients receiving
HAART [66]. A cross-sectional multicenter study was done
to determine the prevalence of and risk factors for
hypothyroidism in HIV-infected patients. Of the 350 HIV-
infected patients studied; 16% had hypothyroidism, 2.6%
had overt hypothyroidism, 6.6% had subclinical hypothy-
roidism, and 6.8% had a low level of free T4. The preva-
lence of subclinical hypothyroidism was higher among
HIV-infected men. A nested case-control study was con-
ducted which compared hypothyroid and euthyroid
patients. Only receipt of stavudine and low CD4 cell
count were associated with hypothyroidism [67]. Thyroid
dysfunction seemed, therefore, to be due to medication
and not to autoimmunity. To confirm these data, 22 HIV+
hypothyroid patients and 22 HIV+ euthyroid controls
receiving highly active anti-retroviral therapy were
included in an additional study. No goiter or anti-thyroid
antibodies were detected. Thus, in our experience, HIV is
not a cause of autoimmune thyroiditis [68]. Discordant
data have been published about these risk factors. Mecha-
nisms and screening of patients is discussed in a recent
review [66].
Some individuals possess antibodies that react to HIV-1
Western blot proteins in patterns different from HIV infec-
tion diagnostic. Autoimmune thyroiditis is more frequent
in patients exhibiting these indeterminate HIV-1 Western
blots in comparison with a control cohort of HIV-negative
blots. These data suggested that patients infected with
non-HIV retrovirus could develop thyroid autoimmunity
[69].
II-B-1-b2/Graves' disease (GD)
Autoimmune diseases in HIV/AIDS that have been
reported include GD [65]. Several hypotheses have been
elaborated. Using Southern blot analysis, specific integra-
tion of exogenous sequences homologous to HIV-1 gag
region was only found in genomic DNA of thyrocytes
from patients with GD and not in normal thyrocytes.
These findings suggested that retrovirus-like sequences
could be associated with thyroid autoimmunity [70].
High reverse transcriptase activity which resembled that
demonstrated in retroviruses has been observed in thyroid
tissue extracts obtained by surgery from patients with GD.
The reverse transcriptase existed in the thyroid tissue as a
complex, with endogenous template RNA, and the activity
was confirmed not to be due to other DNA polymerases.
In a permissive genetic and immunological environment,
retroviral DNA integrated into genomic DNA could then
participate to the onset of GD [71]. However, in a study
using sets of primer pairs designed to cover the whole
span of the HIV-1 gag region, neither Southern blot
hybridization nor PCR gave positive signals in any of the
samples examined [72] as confirmed in another study
[73]. Homology between the HIV-I Nef protein and the
human TSHR has been suggested [74]. However, a retro-
spective analysis of serum samples of a patient with GD
revealed lack of anti-thyroid autoantibodies before the
beginning of antiretroviral treatment[75].
Despite many attempts, results to date remain inconclu-
sive concerning a direct role of HIV in the onset of GD but
a special mechanism has been observed – the immune
system recovery. De novo diagnoses of thyroid disease
were identified between 1996 and 2002 in seven HIV
treatment centers. Patients were diagnosed as clinical case
entities and not discovered through thyroid function test
screening. GD was diagnosed in 15 out of 17 patients
diagnosed with AITD. One patient developed hashithyro-
toxicosis and another, hypothyroidism. AITD patients
were more likely than controls to be severely compro-
mised at baseline and to experience greater CD4 incre-
ments following HAART. Regulatory T lymphocytes (Treg)
appear to be important in suppressing autoimmune reac-
tions. It is possible that a relative deficiency of such cells
explains the appearance of GD during immune system
recovery [75,76].
II-B-1-c/Human Intracisternal A-type particles type 1 (HIAP1)
Intracisternal A-type particles (IAPs) are defective retrovi-
ruses that assemble and bud at the membranes of the
endoplasmic reticulum, where they remain as immature
particles consisting of uncleaved polyproteins antigeni-
cally related to HIV [77]. Serum antibodies against HIAP-
I are detectable in 85% of GD patients compared to only
1.9% of controls. They are absent in patients with Hashi-
moto's thyroiditis as well as other forms of non-autoim-
mune thyroid disease. A genetically determined
immunological susceptibility has been demonstrated: the
class II HLA status allows interactions with HIAP-I expo-
sure and this interaction could be a predisposing factor in
the pathogenesis of GD [78]. Intracisternal A-type parti-
cles have been reported in H9 cells co-cultured with
homogenates of salivary glands obtained from patients
with Sjögren syndrome and with synovial fluid of patients
with rheumatoid arthritis. However, no HIAP-1 particles
are detected by electron microscopy in the H9 cells co-cul-
tured with thyroid preparations of GD. These data call
into question the involvement of HIAP-1 in the etio-
pathogenesis of Graves' disease [79].
II-B-1-d/Human Foamy Virus (HFV)
Human foamy virus (HFV) is a member of the retroviral
family of Spumaretroviridae. Three retroviral structuralVirology Journal 2009, 6:5 http://www.virologyj.com/content/6/1/5
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proteins of HFV – gag, pol and env – can be identified by
indirect immunofluorescence.
II-B-1-d1/Hashimoto's thyroiditis
From the thyroids of five patients with Hashimoto's dis-
ease, four were negative for the structural protein and one
showed a single small focus of anti-gag antibody reactivity
[19].
II-B-1-d2/Graves' disease
Contrary to what has been found in Hashimoto's thy-
roiditis, the expression of HFV gag proteins has been dem-
onstrated by indirect immunofluorescence on the
epithelial cells of seven out of seven thyroid glands of
patients with GD whereas it was negative in 9 subacute
thyroiditis and 2 normal glands. The retrobulbar tissue of
1 Graves' disease patient with malignant exophthalmus
revealed also positive staining with anti-gag antibodies in
fibroblasts and fat cells [19,80]. In a search for spumaret-
rovirus infection markers, a group of 29 patients with GD
and 23 controls were studied. A positive signal with a spu-
maretrovirus-specific genomic probe was found in DNA
extracted from peripheral blood lymphocytes in 10
patients and spumaretrovirus related sequences were
detected by PCR in the DNA of 19 patients. All 23 control
subjects were negative. These results strongly suggest the
existence of an association between GD and the presence
of spumaretrovirus related infection markers[81]. Other
studies failed to detect the presence of antibodies by sev-
eral immunodetection techniques and foamy virus DNA
in peripheral blood lymphocytes [20,82] and the presence
of the spumaretrovirus gag region sequence was not statis-
tically significant in DNA extracted from the peripheral
blood leukocytes and thyroid tissue of 81 patients with
GD and of 66 controls [83]. Nevertheless, the nature of
the HFV-related sequences identified in the genomes of
healthy individuals and the GD patients appeared to be
different. Three regions of HFV-related sequences were
amplified in 29% of the HFV-positive patients, while no
samples in the control group amplified all three regions.
This suggests that these sequences may be used as a tool
for screening for HFV in GD patients [84].
These studies provide no evidence for a causative role for
HFV in GD. However, the data do represent the possibility
that HFV-like sequences may be implicated and this is a
possibility especially in some geographically distinct pop-
ulations [21].
II-B-1e/Simian virus (SV40)
Simian virus 40 (SV40) is a polyomavirus that is found in
both monkeys and humans. Like other polyomaviruses,
SV40 is a DNA virus that has the potential to cause tumors
but most often persists as a latent infection. In a study
dedicated to thyroid tumors, SV40 sequences were also
investigated in GD thyroid specimens, normal thyroid tis-
sues, and peripheral blood mononuclear cells of healthy
donors. Specific SV40 large T antigen sequences were
detected, by PCR and filter hybridization, in human thy-
roid tissues from GD patients, with a frequency of 20%
compared with a frequency of 10% of control normal thy-
roid tissues from patients affected by multinodular goiter
[85].
II-B-2/Rubella virus (German measles)
Thyroid disorders in patients with congenital rubella were
first reported in 1975 [86]. Infection of thyroid tissue by
rubella was demonstrated in a case of congenital rubella
with Hashimoto's thyroiditis: immunofluorescent studies
of thyroid tissue demonstrated staining for rubella virus
antigen [87]. Thyroid autoantibodies, anti-TPO or anti-Tg
antibodies have been found more frequently in patients
with congenital rubella syndrome than in controls
[88,89]. These studies are old and a recent study has
shown that humoral autoimmunity was not so frequent.
In 37 subjects affected by or exposed to rubella during
fetal life, one patient had diabetes, four patients had clin-
ical hypothyroidism and five patients were positive for
TPOAb at the time of the examination [90]. However, in
an Australian study, the prevalence of thyroid disorders,
as well as diabetes and early menopause, was higher in
subjects with congenital rubella (studied 60 years after
their intrauterine infection) than the general population.
It is worthy of note that 41% of the subjects had undetec-
table levels of rubella antibodies [91]. Since most reports
have shown no evidence of active rubella infection at the
time of thyroid dysfunction, the mechanisms proposed
for thyroid dysfunction are destruction of thyroid cells by
local persistent rubella virus infection, precipitation of an
autoimmune reaction, or both [92-96].
II-B-3/Herpesviridae
The Herpesviridae are a large family of DNA viruses that
share a common structure and a common characteristic
which is latent and re-occurring infections. Herpesviridae
can cause lytic infections.
II-B-3a/Herpes Simplex Virus (HSV) and Cytomegalovirus (CMV)
Thyroid tissue specimens were obtained postoperatively
from four patients with multinodular goiter and 18
patients with AITD (GD and Hashimoto thyroiditis). Her-
pesviridae DNA was detected using PCR-based assays.
Herpesviridae DNA has been more frequently detected in
AITD tissue specimens than in tissue specimens of multi-
nodular goiters. No statistically significant differences
were observed concerning the specific strains HSV1,
HSV2, HSV 6 or HSV7. No CMV DNA was isolated from
any tissue specimen [97].
II-B-3b/Epstein Barr Virus (EBV)
EBV infection is known to be involved in tumoral diseases
such as lymphoma but also in autoimmune diseases, suchVirology Journal 2009, 6:5 http://www.virologyj.com/content/6/1/5
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as multiple sclerosis, rheumatoid arthritis and systemic
lupus erythematosus [98]. Antibodies against EBV viral
capsid antigen (IgG-VCA) and antibodies against early
antigen (IgG-EA-D/DR) have been more often found in
thyroiditis than in controls [99]. What is unusual is that
EBV may induce anti-T3 antibodies. Acute EBV infection
with severe primary hypothyroidism was described in a
16-year old female patient. She had high low FT4 and low
FT3 but discordant elevated total T3. Later, 34 patients
with EBV infection were tested for thyroid hormone lev-
els. Five patients with acute EBV and one with previous
infection had total T3 values above the mean which was
due to anti-T3 antibodies [100].
II-B-3c/Human Herpes Virus (HHV)
HHV are ubiquitous, tissue tropism widespread. HHV6
and HHV7 circulating DNA was searched in sixty Graves
disease patients paired to 60 controls. Both viruses infec-
tion increased the risk for Graves disease especially HHV7
that was significantly more frequent among patients
(64.6%) than in controls (38.7%). Patients 72TP53 Pro/
Pro variants (inherited diminished TP53 apoptotic func-
tion) had 5 times more chance to develop GD and almost
three times more chance to be infected by HHV7 which is
consistent with interaction between genetics and viral
infection in Graves disease physiopathology[101].
II-B-4/Parvovirus
The B19 virus belongs to the Parvoviridae family of small
DNA viruses. Parvovirus B19 is known for causing a child-
hood exanthem but it has also been associated with
autoimmune diseases: autoimmune neutropenia, throm-
bocytopenia, hemolytic anemia and rheumatoid arthritis
[102]. Recently, a few studies have suggested the associa-
tion of parvovirus infection with thyroiditis.
II-B-4a/Hashimoto's thyroiditis
Intrathyroidal persistence of human parvovirus B19 DNA
with PCR has been detected for the first time in a patient
with Hashimoto's thyroiditis. The cell types responsible
for the B19 DNA persistence are not determined and
immune cells infiltrating the thyroid may be the source of
B19 DNA. However, the possibility that thyroid epithelial
cells harbor B19 DNA cannot be excluded [103].
Serum samples from 73 children and adolescents with
Hashimoto's thyroiditis and from 73 age-matched con-
trols have been analyzed for the presence of specific anti-
bodies. No differences are observed. But Parvovirus B19
DNA, indicating recent B19-infection, is detectable more
frequently in patients and a negative correlation exists
with disease duration. There is strong evidence that acute
parvovirus B19 infections are involved in the pathogene-
sis of some cases of Hashimoto's thyroiditis[104].
Parvovirus may also be present in the brain. Some authors
hypothesize that parvovirus B19 is a common human
pathogen which could explain the association between
mental disorders and thyroid diseases because of its abil-
ity to infect the brain and to induce autoimmunity. This
hypothesis is based on the fact that they found in patients
with bipolar disorder both a thyroid disorder and brain
B19 infection [105].
II-B-4b/Graves' disease
A woman, whose son had an episode of exanthem two
weeks previously, was infected with parvovirus and suf-
fered successively GD, type-1 diabetes and rheumatic pol-
yarthritis. Serological tests showed IgM antibodies to
human parvovirus B19, but no IgM antibodies to cytome-
galovirus, Epstein Barr virus, rubella, measles, or Cox-
sackie viruses. Anti-TSH receptor antibody was positive.
Parvovirus viral protein 1 was detected in her bone mar-
row samples but no analysis was done on thyroid tissue
[106].
II-B-5/Viral Hepatitis C and B (HCV and HBV)
Discordant data are published about hepatitis. Thyroid
involvement may be regarded as the most frequent altera-
tion in HCV positive patients and is more frequent than in
HVB. The prevalence of abnormally high levels of anti-
thyroid antibodies varied markedly, ranging from 2% to
48% and subclinical hypothyroidism has been observed
in 2 to 9% of patients with chronic hepatitis C [107,108].
In a retrospective cohort study which included 146,394
patients infected with HCV (individuals with human
immunodeficiency virus were excluded) and 572,293
patients uninfected with HCV, thyroiditis risk was slightly
increased, but there was no analysis of treatment [109].
The prevalence of autoimmune thyroid disease in patients
with HCV differs from that in patients with the hepatitis B
virus (HBV) before, at the end of, and 6 months after stop-
ping treatment with IFN-alpha. Positive levels of TPOAb
and TgAb were found in 20% and 11% of patients with
HCV compared with 5% and 3% of patients with HBV,
respectively. At the end of IFN-alpha therapy, thyroid
gland dysfunction was more prevalent in patients with
HCV (12%) compared with those with HBV (3%), with
TSH levels significantly higher in the HCV group [110].
Other authors don't find an association between hepatitis
C virus and thyroid autoimmunity [111,112]. Thyroid
autoimmunity may be a cytokine-induced disease in sus-
ceptible patients. Indeed, the incidence is much greater in
females and positive anti-TPOAb patients prior to the ini-
tiation of therapy. According Marazuela, thyroid dysfunc-
tion secondary to interferon is reversible after
discontinuation of therapy [113], which is discordant
with Fernandez' data [110]. Variable geographic distribu-
tion has also shown that genetic or environmental influ-
ences could be implicated [114]. On the whole, theVirology Journal 2009, 6:5 http://www.virologyj.com/content/6/1/5
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distinctive role of the virus itself or antiviral treatment
remains to be clarified. Abnormalities in thyroid function
should be included among the complications of HCV syn-
drome and patients should be periodically screened for
thyroid involvement in order to identify patients in need
of treatment as quoted in a recent review [107].
II-B-6/SARS coronavirus (SARS-CoV)
A substantial number of patients with SARS have shown
abnormalities in thyroid function. As SARS is a disease
known to cause multiple organ injury, it has been sup-
posed that SARS could have a harmful effect on the thy-
roid gland. However, low serum triiodothyronine and
thyroxine levels associated with decreased TSH concentra-
tion are in favor of central hypothyroidism induced by
hypophysitis or by hypothalamic dysfunction [115].
II-B-7/Enterovirus
II-B-7-a/Hashimoto's thyroiditis
Enteroviruses play a role in immune-mediated pathologi-
cal processes, such as chronic myositis and chronic dilated
cardiomyopathy [116]. Epidemiologic and prospective
studies have provided a body of arguments that strongly
suggest the role of enteroviruses in type-1 diabetes in
which, interestingly, AITD is frequently observed
[117,118]. Recently, we have shown that EV-RNA can be
detected by real-time PCR in thyroid tissue from patients
with various thyroid diseases, but no relationship
between the presence of EV-RNA and thyroiditis, lym-
phocytic infiltration or the presence of circulating TPOAb
was found. Although the patients in our series are cer-
tainly different from patients with classic Hashimoto's
thyroiditis, which are rarely treated surgically, our results
suggest that the presence of EV-RNA in thyroid tissue is
not associated with autoimmune thyroiditis. It's worthy
to note that EV-RNA was detected in one patient with a
normal thyroid [119]. Maternal enterovirus infection dur-
ing pregnancy has been linked to thyroiditis in children.
Sera taken at delivery from mothers whose children sub-
sequently developed AITD was analyzed for antibodies
against enterovirus, and compared with a control group.
Of the mothers whose children developed AITD, 16%
were enterovirus IgM-positive, compared with 7% in the
control group which was not statistically different. How-
ever, the age at diagnosis of AITD was significantly lower
in the group of children with IgM-positive mothers com-
pared with children with IgM-negative mothers. Also
hypothyroidism was significantly more frequent in the
IgM-positive group, with no child in the IgM-negative
group [120].
II-B-7-b/Graves' disease
Patients with recent onset of Graves' hyperthyroidism
(about two months before blood sample collection) have
been investigated in regard to enterovirus infection. A
nested PCR reaction with primers of the enterovirus
genome was employed on blood samples but all were
negative for RNA of the enterovirus group [121].
II-C/Viral involvement in the etiology of hypothyroidism: animal 
models data
Reovirus infection of a neonatal mouse can induce thy-
roiditis and thyroid autoimmunity. Mice infected with
reovirus type 1 develop a thyroiditis characterized by focal
destruction of acinar tissue, infiltration of the thyroid by
inflammatory cells, and production of autoantibodies
directed against thyroglobulin and thyroid microsomes
[122]. The segment of the reovirus type 1 genome respon-
sible for the induction of autoantibodies to thyroglobulin
encodes a polypeptide that binds to surface receptors and
determines the tissue tropism of the virus [123].
An endogenous retrovirus (ev 22) was found to be
expressed in obese-strain (OS) chickens but not in healthy
normal strains. Ev 22 is inherited autosomally in a domi-
nant manner. The OS chickens develop a hereditary spon-
taneous autoimmune thyroiditis characterized
histologically by lymphocytic infiltration of the thyroid
gland. Thyroiditis is associated with obesity and hyperlip-
idemia. A similar thyroiditis has also been induced in nor-
mal chickens by retroviral infection [124].
Lymphocytic choriomeningitis virus (LCMV) can persist
in the thyroid gland of three strains of mice neonatally
infected with the virus. Furthermore, the virus that was
shown to persist mainly in the thyroid epithelial cells in
which thyroglobulin is synthesized induced a reduction in
the level of thyroglobulin messenger RNA and circulating
thyroid hormones, but there was no thyroid cell destruc-
tion. Then persistent, apparently benign virus infection
with LCMV, can be induced in the thyroid of mice and this
infection induces thyroid dysfunction. This alteration in
thyroid homeostasis is not caused to the thyroid by
autoantibodies. Moreover, despite infection of the thyroid
gland, neither necrosis nor inflammation occurs [125].
Animals models show that a typical autoimmune thy-
roiditis can be induced by a direct viral infection but also
by an inherited retrovirus infection. These models also
show that thyroid dysfunction can occur without inflam-
mation or antithyroid autoantibodies. Further studies are
then needed in humans to explore the role of viruses in
the pathogenesis of thyroid dysfunctions.
III/Lymphomas and Riedel's thyroiditis
Lymphomas and Riedel's thyroiditis are rare disorders but
both can occur in association with Hashimoto's thyroidi-
tis.Virology Journal 2009, 6:5 http://www.virologyj.com/content/6/1/5
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III-A/Riedel's thyroiditis
Fibrous thyroiditis, also known as Riedel's thyroiditis, is
characterized by extensive fibrosis and mononuclear infil-
tration that extends into adjacent tissues. It may consist in
a primary fibrosing disorder or in the local involvement of
a multifocal fibrosclerosis. The etiology of Riedel's thy-
roiditis is not known. It can occur in association with
Hashimoto's thyroiditis [126]. As this disease is rare, the
literature is scarce.
Two cases of Riedel's thyroiditis onset have been reported
after a subacute thyroiditis, which is thought, as already
said, to be a viral induced disaese. Two women, first diag-
nosed with sub-acute thyroiditis, developed an enlarge-
ment of the thyroid gland and symptoms of compression
eight months and three years later, respectively. Post-oper-
ative histopathologic evaluation showed Riedel's thy-
roiditis characteristics associated with sub-acute
thyroiditis [127,128].
Only one case report of infection has been reported in
international literature. A 36-year old woman had of long-
term fever associated with a biologic inflammatory syn-
drome which was reported as due to EBV infection
because of a positive EBV serology. TSH concentration,
levels of TPOAb and thyrocalcitonin were normal. There
was a dramatic improvement after thyroidectomy with
normalization of inflammatory parameters. The role of
EBV infection in the process of this unusual form of
Riedel's thyroiditis was suspected [129].
III-B/Lymphomas
Thyroid lymphomas are nearly always of the non-Hodg-
kin's type. Hodgkin's lymphoma of the thyroid is exceed-
ingly rare. Preexisting chronic autoimmune thyroiditis is
the only known risk factor for primary thyroid lym-
phoma, and is present in about one-half of patients [130].
III-B-1/Epstein Barr Virus (EBV)
Epstein-Barr virus (EBV) is found in many lymphomas.
The clinicopathological characteristics in the Hong Kong
Chinese population and the presence of EBV in thyroid
lymphomas were analyzed by reviewing data collected
over three decades. EBV gene expression by in-situ hybrid-
ization and immunohistochemistry were performed. Pri-
mary thyroid lymphomas were found in 23 patients and
secondary lymphomas were found in 9 patients. EBV mes-
senger RNAs were detected in one primary and one sec-
ondary thyroid lymphoma [131].
One study explored the association of EBV with thyroid
lymphoma (TL) and with chronic lymphocytic thyroiditis
(CLTH) which is known to play an important role in the
development of TL. Thirty cases with TL and 28 with
CLTH were studied for presence or absence of EBV
genome in the lesions, using the polymerase chain reac-
tion (PCR) and the in-situ hybridization method. EBV
genomes were detected by PCR in one CLTH and two TL.
In-situ hybridization revealed positive signals in the
nucleus of lymphoma cells, which also expressed latent
membrane protein-1 [132].
EBV-related mRNA presence was investigated in 32 cases
of malignant lymphoma of the thyroid by in-situ hybrid-
ization and immunohistochemistry. EBV-encoded small
RNA were detected in three cases [133]. These findings
indicate that EBV implication in TL is possible but not
common.
III-B-2/Enterovirus
A patient with autoimmune thyroiditis had a transitory
recurrence of her goiter during pregnancy with TPOAb
becoming strongly positive. Six months post partum she
had a subacute thyroiditis. Serology established the diag-
nosis of viral thyroiditis due to a Coxsackie-B virus. Two
months later the goiter showed further growth, in associ-
ation with cervical lymphadenopathy and an enlarged left
parotid gland. Histology revealed a primary thyroid lym-
phoma.
III-B-3/Human T Lymphotropic Virus (HTLV1)
Thyroid non-Hodgkin's lymphoma in an area in which
adult T-cell leukemia/lymphoma (ATL) is not endemic is
exclusively B-cell derived. A study was carried out to exam-
ine whether thyroid non-Hodgkin's lymphoma in an area
in which ATL is endemic is also exclusively of B-cell type.
Eight cases with thyroid non-Hodgkin's lymphoma
admitted to the hospital situated in an ATL-endemic area
were studied. Immunophenotypic study revealed all but
one case to be of B-cell nature The T-cell type lymphoma
case also had antibodies against HTLV-1 in the serum
[134].
III-B-4/Viral hepatitis C (HCV)
Lymphomas are frequent in HCV-infected patients but no
thyroid lymphoma has been reported in these
patients[107].
III-B-5/Human Immunodeficiency Virus (HIV)
Two cases of thyroid lymphoma have been described in
HIV-infected patients. The first is a 31-year old woman
with acquired immunodeficiency syndrome (AIDS) who
presented a severe thyrotoxicosis and a markedly
enlarged, diffuse, tender goiter. The patient died within
days of her presentation. At autopsy, near-complete
replacement of the thyroid gland with anaplastic large cell
lymphoma was found, without coexisting infectious or
autoimmune processes in the gland [135]. The second
case was a child with vertical transmission-acquired HIV,
presenting with lymphomatous infiltration of the thyroid
gland at diagnosis [136].Virology Journal 2009, 6:5 http://www.virologyj.com/content/6/1/5
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Conclusion
Identifying etiological infections in human disease is dif-
ficult. Besides the fact that organ tissue is not always avail-
able for direct study, the interpretation of virological data
must be cautious. The presence of antibodies directed
towards a virus does not prove that this pathogen is
responsible for the disease, especially when the agent is
common in the general population. On the other hand,
the absence of viral markers at the onset of the disease
does not refute the viral hypothesis. Indeed the triggering
infection can take place many years previously. A trigger-
ing virus can be cleared from the body without any viro-
logical trace except the presence of specific antibodies. It
is relevant to look for viral agents in tissues in which they
can persist without systemic manifestation. Direct evi-
dence of the presence of viruses or their components in
the organ are available for retroviruses (HFV) and mumps
in subacute thyroiditis, for retroviruses (HTLV-1, HFV,
HIV and SV40) in Graves's disease and for HTLV-1, enter-
ovirus, rubella, mumps virus, HSV, EBV and parvovirus in
Hashimoto's thyroiditis. However, it remains to deter-
mine whether they are responsible for thyroid diseases or
whether they are just innocent bystanders.
A viral disease is the result of an interaction between a
virus and the host, in which the genetic background plays
a role. Therefore, it cannot be excluded that a virus plays a
role in a disease even though most infected individuals do
not show any sign of disease.
Further studies are needed to clarify the relationship
between viruses and thyroid diseases, in order to develop
new strategies for their prevention and/or the treatment.
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